HENDERSON JANE (Chief Financial Officer) reported 1 transaction at APOGEE THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/25/2026ACC: 0001104659-26-086729
Officer· Chief Financial Officer
Since Mar 2026
-15K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
15K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−15K
Price / share
—
Trade value
—
% of position
8.7%
7/24/2026
173.37K→158.37K
Total
Net shares
−15K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/24/2026 | G · Gift | −15K | — | — | 8.7% | 173.37K | 158.37K |
| Total | −15K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported